Related Experiment Video
Updated: Feb 1, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by
Sijia Chen1,2, Troy Noordenbos1,2, Iris Blijdorp1,2
1Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
Objectives:
Synovial mast cells contain IL-17A, a key driver of tissue inflammation in SpA. A recent in vitro study showed that tissue-derived mast cells can capture and release exogenous IL-17A. The present study aimed to investigate if this mechanism could contribute to tissue inflammation in SpA.
Methods:
Potential activation of mast cells by IL-17A was assessed by gene expression analysis of the Laboratory of Allergic Diseases 2 (LAD2) mast cell line. The presence of IL-17A-positive mast cells was assessed by immunohistochemistry in synovial tissue obtained before and after secukinumab treatment, as well as in skin and gut tissues from SpA-related conditions.
Results:
IL-17A did not induce a pro-inflammatory response in human LAD2 mast cells according to the canonical IL-17A signalling pathway. In SpA synovial tissue, the percentage of IL-17A-positive mast cells increased upon treatment with secukinumab. IL-17A-positive mast cells were also readily detectable in non-inflamed barrier tissues such as skin and gut. In non-inflamed dermis and gut submucosa, IL-17A-positive mast cells are the most prevalent IL-17A-positive cells in situ. Compared with non-inflamed tissues, both total mast cells and IL-17A-positive mast cells were increased in psoriatic skin dermis and in submucosa from inflammatory bowel disease gut. In contrast, the proportion of IL-17A-positive mast cells was strikingly lower in the inflamed compared with non-inflamed gut lamina propria.
Conclusion:
IL-17A-positive mast cells are present across SpA target tissues and correlate inversely with inflammation, indicating that their IL-17A content can be regulated. Tissue-resident mast cells may act as IL-17A-loaded sentinel cells, which release IL-17A to amplify tissue inflammation.
Insights
Mast cells in SpA tissues store IL-17A, a key inflammatory driver. These sentinel cells may release IL-17A to amplify inflammation, though their IL-17A content appears regulated by disease state.
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Mast cells in synovial tissue contain Interleukin-17A (IL-17A), a critical mediator of inflammation in Spondyloarthritis (SpA).
- In vitro studies suggest mast cells can capture and release exogenous IL-17A, raising questions about their role in SpA pathogenesis.
Purpose of the Study:
- To investigate whether mast cells contribute to SpA tissue inflammation by capturing and releasing IL-17A.
- To assess the presence and regulation of IL-17A-positive mast cells in SpA target tissues.
Main Methods:
- Gene expression analysis of the LAD2 mast cell line to assess potential IL-17A activation.
- Immunohistochemistry to detect IL-17A-positive mast cells in synovial, skin, and gut tissues from SpA patients, before and after secukinumab treatment.
Main Results:
- IL-17A did not induce a pro-inflammatory response in LAD2 mast cells via the canonical pathway.
- IL-17A-positive mast cells were found in SpA synovial tissue, skin, and gut, increasing after secukinumab treatment.
- While increased in psoriatic skin and IBD gut submucosa, IL-17A-positive mast cells were less abundant in inflamed gut lamina propria compared to non-inflamed tissue.
Conclusions:
- IL-17A-positive mast cells are present in SpA target tissues and their IL-17A content is regulated, inversely correlating with inflammation.
- Tissue-resident mast cells may function as IL-17A reservoirs, releasing the cytokine to potentially amplify tissue inflammation in SpA.
Related Concept Videos
Inflammation
The Evidence for Evolution
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Binet's Contribution to Measures of Intelligence
Regulated mRNA Transport
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...

